Healthcare & Life Sciences
Linnaeus Therapeutics
United Stateslinnaeustx.com/
Linnaeus Therapeutics is a Healthcare & Life Sciences startup based in the United States.
About Linnaeus Therapeutics
Based in the United States, Linnaeus Therapeutics is a startup. Brouky classifies it under Healthcare & Life Sciences.
Linnaeus Therapeutics is a development-stage biotech company developing small molecule drugs for cancer treatment; its lead compound LNS8801 is an orally bioavailable, potent GPER agonist currently in Phase 1/2a clinical trials, including combination studies with Merck's anti-PD-1 therapy KEYTRUDA.
Explore Linnaeus Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.